ABVC BioPharma, Inc.
ABVC
$1.30
$0.075.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.56M | -1.25M | -2.26M | -842.10K | -731.60K |
| Total Depreciation and Amortization | 214.00K | 96.00K | 80.80K | 113.90K | -122.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.00M | 1.18M | 1.65M | 207.60K | 459.60K |
| Change in Net Operating Assets | -71.90K | -158.20K | -365.90K | -19.30K | -307.90K |
| Cash from Operations | -1.42M | -133.30K | -894.20K | -539.80K | -702.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 730.30K | -1.27M | -665.80K | -- | 456.80K |
| Cash from Investing | 730.30K | -1.27M | -665.80K | -- | 456.80K |
| Total Debt Issued | 730.00K | 150.00K | 9.00K | -- | -155.60K |
| Total Debt Repaid | -108.70K | -335.70K | -74.10K | -29.30K | -177.00K |
| Issuance of Common Stock | 528.20K | 1.32M | 2.04M | 411.70K | 76.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -7.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -46.30K | 46.30K | 599.60K |
| Cash from Financing | 1.15M | 1.13M | 1.93M | 428.80K | 335.80K |
| Foreign Exchange rate Adjustments | 12.20K | 51.80K | -50.60K | 6.80K | 3.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 473.10K | -222.40K | 316.80K | -104.20K | 93.90K |